Characterization of a novel necrotic granuloma model of latent tuberculosis infection and reactivation in mice

American Journal of Pathology

Volumn 184, Issue 7, 2014, Pages 2045-2055

  Dutta, Noton K ^a   Illei, Peter B ^a   Jain, Sanjay K ^a   Karakousis, Petros C ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL2 CHEMOKINE; CXCL3 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; TUMOR NECROSIS FACTOR; CYTOKINE; NEUTRALIZING ANTIBODY; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; HYPOXEMIA; INFLAMMATION; LATENT TUBERCULOSIS; LUNG GRANULOMA; MICROARRAY ANALYSIS; MORTALITY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NECROSIS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; C3H MOUSE; DISEASE MODEL; GRANULOMA; LUNG; METABOLISM; MICROBIOLOGY; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GRANULOMA; LATENT TUBERCULOSIS; LUNG; MICE, INBRED C3H; NECROSIS; TRANSCRIPTOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84903180280     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.03.008     Document Type: Article

References (50)

1. Y.C. Manabe, and W.R. Bishai Latent Mycobacterium tuberculosis- persistence, patience, and winning by waiting Nat Med 6 2000 1327 1329
2. E.L. Nuermberger, T. Yoshimatsu, S. Tyagi, W.R. Bishai, and J.H. Grosset Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG Infect Immun 72 2004 1065 1071
3. T. Zhang, S.Y. Li, K.N. Williams, K. Andries, and E.L. Nuermberger Short-course chemotherapy with TMC207 and rifapentine in a murine model of latent tuberculosis infection Am J Respir Crit Care Med 184 2011 732 737
4. C.R. Diedrich, and J.L. Flynn HIV-1/mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis? Infect Immun 79 2011 1407 1417
5. J. Flynn, and J. Chan Animal models of tuberculosis W. Rom, S. Garay, Tuberculosis ed 2 2004 Lippincott Williams & Wilkins Philadelphia 237 250
6. D.N. McMurray Disease model: pulmonary tuberculosis Trends Mol Med 7 2001 135 137
7. E.L. Opie, and J.D. Aronson Tubercle bacilli in latent tuberculous lesions and in lung tissue without tuberculous lesions Arch Pathol Lab Med 4 1927 1 21
8. P.L. Lin, and J.L. Flynn Understanding latent tuberculosis: A moving target J Immunol 185 2010 15 22
9. S. Subbian, P. O'Brien, N.L. Kushner, G. Yang, L. Tsenova, B. Peixoto, N. Bandyopadhyay, J.S. Bader, P.C. Karakousis, D. Fallows, and G. Kaplan Molecular immunologic correlates of spontaneous latency in a rabbit model of pulmonary tuberculosis Cell Commun Signal 11 2013 16
10. H. Pan, B.S. Yan, M. Rojas, Y.V. Shebzukhov, H. Zhou, L. Kobzik, D.E. Higgins, M.J. Daly, B.R. Bloom, and I. Kramnik Ipr1 gene mediates innate immunity to tuberculosis Nature 434 2005 767 772
11. J. Harper, C. Skerry, S.L. Davis, R. Tasneen, M. Weir, I. Kramnik, W.R. Bishai, M.G. Pomper, E.L. Nuermberger, and S.K. Jain Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions J Infect Dis 205 2012 595 602
12. L.E. Via, P.L. Lin, S.M. Ray, J. Carrillo, S.S. Allen, S.Y. Eum, K. Taylor, E. Klein, U. Manjunatha, J. Gonzales, E.G. Lee, S.K. Park, J.A. Raleigh, S.N. Cho, D.N. McMurray, J.L. Flynn, and C.E. Barry 3rd Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates Infect Immun 76 2008 2333 2340
13. C. Vilaplana, E. Marzo, G. Tapia, J. Diaz, V. Garcia, and P.J. Cardona Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis J Infect Dis 208 2013 199 202
14. E.R. Driver, G.J. Ryan, D.R. Hoff, S.M. Irwin, R.J. Basaraba, I. Kramnik, and A.J. Lenaerts Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis Antimicrob Agents Chemother 56 2012 3181 3195
15. I.M. Rosenthal, R. Tasneen, C.A. Peloquin, M. Zhang, D. Almeida, K.E. Mdluli, P.C. Karakousis, J.H. Grosset, and E.L. Nuermberger Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis Antimicrob Agents Chemother 56 2012 4331 4340
16. C. Skerry, J. Harper, M. Klunk, W.R. Bishai, and S.K. Jain Adjunctive TNF inhibition with standard treatment enhances bacterial clearance in a murine model of necrotic TB granulomas PLoS One 7 2012 e39680
17. M.A. Horwitz, and G. Harth A new vaccine against tuberculosis affords greater survival after challenge than the current vaccine in the guinea pig model of pulmonary tuberculosis Infect Immun 71 2003 1672 1679
18. C.R. Horsburgh Jr., and E.J. Rubin Clinical practice: latent tuberculosis infection in the United States N Engl J Med 364 2011 1441 1448
19. H.L. Plessner, P.L. Lin, T. Kohno, J.S. Louie, D. Kirschner, J. Chan, and J.L. Flynn Neutralization of tumor necrosis factor (TNF) by antibody but not TNF receptor fusion molecule exacerbates chronic murine tuberculosis J Infect Dis 195 2007 1643 1650
20. Z. Ahmad, L.G. Klinkenberg, M.L. Pinn, M.M. Fraig, C.A. Peloquin, W.R. Bishai, E.L. Nuermberger, J.H. Grosset, and P.C. Karakousis Biphasic kill curve of isoniazid reveals the presence of drug-tolerant, not drug-resistant, Mycobacterium tuberculosis in the guinea pig J Infect Dis 200 2009 1136 1143
21. T. Zhang, M. Zhang, I.M. Rosenthal, J.H. Grosset, and E.L. Nuermberger Short-course therapy with daily rifapentine in a murine model of latent tuberculosis infection Am J Respir Crit Care Med 180 2009 1151 1157
22. S.D. Chakravarty, G. Zhu, M.C. Tsai, V.P. Mohan, S. Marino, D.E. Kirschner, L. Huang, J. Flynn, and J. Chan Tumor necrosis factor blockade in chronic murine tuberculosis enhances granulomatous inflammation and disorganizes granulomas in the lungs Infect Immun 76 2008 916 926
23. V.P. Mohan, C.A. Scanga, K. Yu, H.M. Scott, K.E. Tanaka, E. Tsang, M.M. Tsai, J.L. Flynn, and J. Chan Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology Infect Immun 69 2001 1847 1855
24. S.L. Davis, N.A. Be, G. Lamichhane, S. Nimmagadda, M.G. Pomper, W.R. Bishai, and S.K. Jain Bacterial thymidine kinase as a non-invasive imaging reporter for Mycobacterium tuberculosis in live animals PLoS One 4 2009 e6297
25. M.D. Yates, and C.H. Collins Identification of tubercle bacilli Ann Microbiol (Paris) 130B 1979 13 19
26. T. Espevik, and J. Nissen-Meyer A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes J Immunol Methods 95 1986 99 105
27. L.G. Klinkenberg, L.A. Sutherland, W.R. Bishai, and P.C. Karakousis Metronidazole lacks activity against Mycobacterium tuberculosis in an in vivo hypoxic granuloma model of latency J Infect Dis 198 2008 275 283
28. N.K. Dutta, S. Mehra, A.N. Martinez, X. Alvarez, N.A. Renner, L.A. Morici, B. Pahar, A.G. Maclean, A.A. Lackner, and D. Kaushal The stress-response factor SigH modulates the interaction between Mycobacterium tuberculosis and host phagocytes PLoS One 7 2012 e28958
29. T.C. Mitchell, D. Hildeman, R.M. Kedl, T.K. Teague, B.C. Schaefer, J. White, Y. Zhu, J. Kappler, and P. Marrack Immunological adjuvants promote activated T cell survival via induction of Bcl-3 Nat Immunol 2 2001 397 402
30. D. Nickles, C. Falschlehner, M. Metzig, and M. Boutros A genome-wide RNA interference screen identifies caspase 4 as a factor required for tumor necrosis factor alpha signaling Mol Cell Biol 32 2012 3372 3381
31. C. Ryckman, K. Vandal, P. Rouleau, M. Talbot, and P.A. Tessier Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion J Immunol 170 2003 3233 3242
32. K. Vandal, P. Rouleau, A. Boivin, C. Ryckman, M. Talbot, and P.A. Tessier Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide J Immunol 171 2003 2602 2609
33. S. Shi, A. Blumenthal, C.M. Hickey, S. Gandotra, D. Levy, and S. Ehrt Expression of many immunologically important genes in Mycobacterium tuberculosis-infected macrophages is independent of both TLR2 and TLR4 but dependent on IFN-alphabeta receptor and STAT1 J Immunol 175 2005 3318 3328
34. M. Gonzalez-Juarrero, L.C. Kingry, D.J. Ordway, M. Henao-Tamayo, M. Harton, R.J. Basaraba, W.H. Hanneman, I.M. Orme, and R.A. Slayden Immune response to Mycobacterium tuberculosis and identification of molecular markers of disease Am J Respir Cell Mol Biol 40 2009 398 409
35. J. Marquet, F. Lasoudris, C. Cousin, M.L. Puiffe, N. Martin-Garcia, V. Baud, F. Chereau, J.P. Farcet, V. Molinier-Frenkel, and F. Castellano Dichotomy between factors inducing the immunosuppressive enzyme IL-4-induced gene 1 (IL4I1) in B lymphocytes and mononuclear phagocytes Eur J Immunol 40 2010 2557 2568
36. A. Kipnis, R.J. Basaraba, I.M. Orme, and A.M. Cooper Role of chemokine ligand 2 in the protective response to early murine pulmonary tuberculosis Immunology 109 2003 547 551
37. U.A. Maus, K. Waelsch, W.A. Kuziel, T. Delbeck, M. Mack, T.S. Blackwell, J.W. Christman, D. Schlondorff, W. Seeger, and J. Lohmeyer Monocytes are potent facilitators of alveolar neutrophil emigration during lung inflammation: role of the CCL2-CCR2 axis J Immunol 170 2003 3273 3278
38. F. Deveci, H.H. Akbulut, T. Turgut, and M.H. Muz Changes in serum cytokine levels in active tuberculosis with treatment Mediators Inflamm 2005 2005 256 262
39. M. Zhang, Y. Lin, D.V. Iyer, J. Gong, J.S. Abrams, and P.F. Barnes T-cell cytokine responses in human infection with Mycobacterium tuberculosis Infect Immun 63 1995 3231 3234
40. M.G. Bonecini-Almeida, J.L. Ho, N. Boechat, R.C. Huard, S. Chitale, H. Doo, J. Geng, L. Rego, L.C. Lazzarini, A.L. Kritski, W.D. Johnson Jr., T.A. McCaffrey, and J.R. Silva Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis Infect Immun 72 2004 2628 2634
41. J. Keane, S. Gershon, R.P. Wise, E. Mirabile-Levens, J. Kasznica, W.D. Schwieterman, J.N. Siegel, and M.M. Braun Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent N Engl J Med 345 2001 1098 1104
42. R.S. Wallis, M. Broder, J. Wong, A. Lee, and L. Hoq Reactivation of latent granulomatous infections by infliximab Clin Infect Dis 41 Suppl 3 2005 S194 S198
43. M.A. Rahat, B. Marom, H. Bitterman, L. Weiss-Cerem, A. Kinarty, and N. Lahat Hypoxia reduces the output of matrix metalloproteinase-9 (MMP-9) in monocytes by inhibiting its secretion and elevating membranal association J Leukoc Biol 79 2006 706 718
44. Y.V. Cavalcanti, M.C. Brelaz, J.K. Neves, J.C. Ferraz, and V.R. Pereira Role of TNF-alpha, IFN-gamma, and IL-10 in the development of pulmonary tuberculosis Pulm Med 2012 2012 745483
45. R. Vankayalapati, B. Wizel, S.E. Weis, P. Klucar, H. Shams, B. Samten, and P.F. Barnes Serum cytokine concentrations do not parallel Mycobacterium tuberculosis-induced cytokine production in patients with tuberculosis Clin Infect Dis 36 2003 24 28
46. M. Frahm, N.D. Goswami, K. Owzar, E. Hecker, A. Mosher, E. Cadogan, P. Nahid, G. Ferrari, and J.E. Stout Discriminating between latent and active tuberculosis with multiple biomarker responses Tuberculosis 91 2011 250 256
47. S.E. Jones, R.G. Mennel, B. Brooks, M.A. Westrick, M.A. Allison, R.S. Paulson, K. Tilmann, and B. Rea Phase II study of mitoxantrone, leucovorin, and infusional fluorouracil for treatment of metastatic breast cancer J Clin Oncol 9 1991 1736 1739
48. M.P. Berry, C.M. Graham, F.W. McNab, Z. Xu, S.A. Bloch, T. Oni, K.A. Wilkinson, R. Banchereau, J. Skinner, R.J. Wilkinson, C. Quinn, D. Blankenship, R. Dhawan, J.J. Cush, A. Mejias, O. Ramilo, O.M. Kon, V. Pascual, J. Banchereau, D. Chaussabel, and A. O'Garra An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis Nature 466 2010 973 977
49. R.M. McCune Jr., W. McDermott, and R. Tompsett The fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique, II: The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug J Exp Med 104 1956 763 802
50. A.J. Lenaerts, P.L. Chapman, and I.M. Orme Statistical limitations to the Cornell model of latent tuberculosis infection for the study of relapse rates Tuberculosis (Edinb) 84 2004 361 364